Activation of p65 NF-κB protein by p210(BCR-ABL) in a myeloid cell line (p210(BCR-ABL) activates p65 NF-κB)

Oncogene

Volumn 15, Issue 19, 1997, Pages 2267-2275

  Hamdane, Malika ^a   David Cordonnier, Marie Helene ^a   D'Halluin, Jean Claude ^a  

^a INSERM   (France)

Author keywords

Myeloid cells; NF B activity; p210(BCR ABL); p65 NF B (RelA); Signal transduction; Tyrosine kinase

Indexed keywords

CHIMERIC PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BONE MARROW CULTURE; CHRONIC MYELOID LEUKEMIA; ELECTROPHORETIC MOBILITY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMYELOCYTE;

ANIMALIA; MURINAE;

EID: 0030725774     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201411     Document Type: Article

References (75)

1. Afar DEH, Goga A, McLaughlin J, Witte ON and Sawyers CL. (1994). Science, 264, 424-426.
2. Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, Jonat C, Herrlich P and Karin M. (1987). Cell, 49, 729-739.
3. Bartram CR, de Klein A, Hagemeijer A, van Agthoven T, von Kessel AG, Bootsma D, Grosveld G, Ferguson-Smith MA, Davies T, Stone M, Heisterkamp N, Stephenson JR and Groffen J. (1983). Nature (London), 306, 277-280.
4. Bazzoni G, Carlesso N, Griffin JD and Hemler ME. (1996). J. Clin. Invest., 98, 521-528.
5. Beg AA, Sha WC, Broson RT, Ghost S and Baltimore D. (1995). Nature, 375, 167-170.
6. Brown AM, Linhoff WM, Stein B, Wright KE, Baldwin Jr AS, Basta PV and Ting JP-Y. (1994). Mol. Cell. Biol., 14, 2926-2935.
7. Carlesso N, Griffin JD and Druker BJ. (1994). Oncogene, 9, 149-156.
8. Cook WD. (1982). Proc. Natl. Acad. Sci. USA, 72, 2917-2921.
9. Cortez D, Kadlec E and Prendergast AM. (1995). Mol. Cell. Biol., 15, 5531-5541.
10. Daley GQ, McLaughlin J, Witte ON and Baltimore D. (1987). Science, 237, 532-535.
11. Daley GQ and Baltimore D. (1988). Proc. Natl. Acad. Sci. USA, 85, 9312-9316.
12. Daley GQ, Van Etten RA and Baltimore D. (1990). Science, 247, 824-830.
13. Danhausser-Rield S, Warmuth M, Druker BJ, Emmerich B and Hallek M. (1996). Cancer Res., 56, 3589-3596.
14. Dignam JD, Lebowitz RM and Roeder RG. (1983). Nucleic Acids Res., 11, 1475-1489.
15. Dobrzanski P, Ryseck R-P und Bravo R. (1994). EMBO J., 13, 4608-4616.
16. Fujita T, Nolan GP, Ghosh S and Baltimore D. (1992). Genes Dev., 6, 775-787.
17. Galiège-Zouitina S, Quief S, Hildebrand M-P, Denis C, Lecoq G, Collyn-d'Hooghe M, Bastard C, Yuille M, Dyer MJS and Kerckaert JP. (1996). Leukemia, 10, 579-587.
18. Gilmore TD, Kocdood M, Piffat KA and White DW. Oncogene, 13, 1367-1378.
19. Goga A, McLaughlin J, Alar DEH, Saffran DC and Witte ON. (1995). Cell. 82, 981-988.
20. Gorman J, Moffat LF and Howard BH. (1982). Mol. Cell. Biol., 2, 1044-1051.
21. Gumbiner BM. (1996). Cell, 84, 345-357.
22. Heisterkamp N, Stephenson JR, Groffen J, Hansen PF, de Klein A, Bartram CR and Grosveld G. (1983). Nature, 306, 239-242.
23. Higgins KA, Perez JR, Coleman TA, Dorshkind K, McComas WA, Sarmiento UM, Rosen CA and Narayanan R. (1993). Proc. Natl. Acad. Sci. USA, 90, 9901-9905.
24. Hynes RO. (1992). Cell, 69, 11-25.
25. Ihle JN. (1985). Contemp. Top. Mol. Immunol., 10, 93-119.
26. Kabarowski JHS, Allen PB and Wiedemann LM. (1994). EMBO J., 13, 5887-5895.
27. Kerr LD. (1994). BioEssays, 16, 453-455.
28. Kitajima I, Shinohara T, Bilakovics J, Brown DA, Xu X and Nerenberg M. (1992). Science, 258, 1792-1795.
29. Klug CA, Gerety SJ, Shah PC, Chen Y-Y, Rice NR, Rosenberg N and Singh R. (1994). Genes Dev., 8, 678-687.
30. Konopka JB, Watanabe SM and Witte ON. (1984). Cell, 37, 1035-1042.
31. Konopka JB and Witte ON. (1985). Mol. Cell. Biol., 5, 3116-3123.
32. Kovary K and Bravo R. (1991). Mol. Cell. Biol., 11, 2451-2459.
33. Kunsch C, Ruben SM and Rosen CA. (1992). Mol. Cell. Biol., 12, 4412-4421.
34. Kurzrock R, Gutterman JH and Tapaz M. (1988). New Engl. J. Med., 315, 990-998.
35. Laemmli UK. (1970). Nature (London), 277, 680-685.
36. Lernbecher T, Müller U and Wirth T. (1993). Nature (London), 365, 767-769.
37. Li W, Kloetzer WS and Arlinghaus RB. (1988). Oncogene, 2, 559-566.
38. Lifshitz B, Fainstein E, Marcelle C, Shtivelman E, Amson R, Gale RP and Canaani E. (1988). Oncogene, 2, 113-117.
39. Liou H-C and Baltimore D. (1993). Current Opinion in Cell Biology, 5, 477-487.
40. Luckow B and Schultz G. (1987). Nucleic Acids Res., 15, 5490.
41. Lugo TG and Witte ON. (1989). Mol. Cell. Biol., 9, 1263-1270.
42. Lugo TG, Pendergast A-M, Muller AJ and Witte ON. (1990). Science, 247, 1079-1082.
43. Mandanas RA, Boswell HS, Lu L and Leibowitz D. (1992). Leukemia, 6, 796-800.
44. Mandanas RA, Leibowitz DS, Gharenbaghi K, Tauchi T, Burgess GS, Miyazawa K, Jayaram HN and Boswell HS. (1993). Blood, 82, 1838-1847.
45. Matsuguchi T, Inhorn RC, Carlesso N, Xu G, Druker B and Griffin JD. (1995). EMBO J., 14, 257-265.
46. McLaughlin J, Chianese E and Witte ON. (1987). Proc. Natl. Acad. Sci. USA, 84, 6558-6562.
47. McWhirter JR and Witte ON. (1991). Mol. Cell. Biol., 11, 1553-1565.
48. McWhirter JR, Galasso DL and Wang JYJ. (1993). Mol. Cell. Biol., 13, 7587-7595.
49. Narayanan R, Lawlor KG, Schaapveld RQJ, Cho KR, Vogelstein B, Tran BP-V, Osborne MP and Telang NT. (1992). Oncogene, 7, 553-561.
50. Narayanan R, Higgins KA, Perez JR, Coleman TA and Rosen CA. (1993). Mol. Cell. Biol., 13, 3802-3810.
51. Naumann M and Scheidereit C. (1994). EMBO J., 13, 4597-4607.
52. Neumann M, Tsapos K, Scheppler JA, Ross J and Franza Jr R. (1992). Oncogene, 7, 2095-2104.
53. Neumann M, Wilisch A, Ma B-C, Druker BJ, Serfling E and Franza Jr BR. (1996). Anticancer Res., 16, 1075-1084.
54. Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N, Batzer A, Rabun KM, Der CJ, Schlessinger J and Gishizky ML. (1993). Cell, 75, 175-185.
55. Perez JR, Higgins-Sochaski KA, Maltese J-Y and Narayanan R. (1994). Mol. Cell. Biol., 14, 5326-5332.
56. Perkins ND, Schmid RM, Duckett CS, Leung K, Rice NR and Nabel GJ. (1992). Proc. Natl. Acad. Sci. USA, 89, 1529-1533.
57. Puil L, Liu J, Gish G, Mbamalu G, Bowtell D, Pelicci PG, Arlinghaus R and Pawson T. (1994). EMBO J., 13, 764-773.
58. Renshaw MW, McWhirter JR and Wang JYJ. (1995). Mol. Cell. Biol., 15, 1286-1293.
59. Reuther GW, Fu H, Cripe LD, Collier RJ and Pendergast AM. (1994). Science, 266, 129-133.
60. Rowley JD. (1973). Nature (London), 243, 290-293.
61. Ruoslahti E and Reed JV. (1994). Cell, 77, 477-478.
62. Salgia R, Brunkhorst B, Pisick E, Li J-L, Lo SH, Chen LB and Griffin JD. (1995a). Oncogene, 11, 1149-1155.
63. Salgia R, Li J-L, Lo SH, Brunkhorst B, Kansas GS, Sobhany ES, Sun Y, Pisick E, Hallek M, Ernst T, Tantravahi R, Chen LB and Griffin JD. (1995b). J. Biol. Chem., 270, 5039-5047.
64. Salgia R, Uemera N, Ukuda K, Li J-L, Pisick E, Sattler M, De Jong R, Druker B, Heisterkamp N, Chen LB, Groffen J and Griffin JD. (1995c). J. Biol. Chem., 270, 29145-29150.
65. Sattler M, Salgia R, Okuda K, Uemura N, Durstin MA, Pisick E, Xu G, Li J-L, Prasad KV and Griffin JD. (1996). Oncogene, 12, 839-846.
66. Sawyers CL, Callahan W and Witte ON. (1992). Cell, 70, 901-910.
67. Sawyers CL, McLaughlin J and Witte ON. (1995). J. Exp. Med., 181, 307-313.
68. Schmitz ML and Baeuerle PA. (1995). Immunobiol., 193, 116-127.
69. Scott ML, Fujita T, Liou H-C, Nolan GP and Baltimore D. (1993). Genes Dev., 7, 1266-1276.
70. Shu HB, Agranoff AB, Nabel EG, Leung K, Duckett CS, Neish AS, Collins T and Nabel GJ. (1993). Mol. Cell. Biol., 13, 6283-6289.
71. Shuai K, Hapern J, ten Hoeve J, Rao X and Sawyers CL. (1996). Oncogene, 13, 247-254.
72. Singh H, Sen R, Baltimore D and Sharpe PA. (1986). Nature (London), 319, 154-158.
73. Sokoloski JA, Sartorelli AC, Rosen CA and Narayanan R. (1993). Blood, 82, 625-632.
74. Staudt LM, Singh H, Sen R, Wirth T, Sharp PA and Baltimore D. (1986). Nature (London), 323, 640-643.
75. Varticovski L, Daley GQ, Jackson P, Baltimore D and Cantley LC. (1991). Mol. Cell. Biol., 11, 1107-1113.